The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Speirs, K.
Right arrow Articles by Scott, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Speirs, K.
Right arrow Articles by Scott, P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Leishmaniasis
The Journal of Immunology, 2002, 168: 4406-4413.
Copyright © 2002 by The American Association of Immunologists

NF-{kappa}B2 Is Required for Optimal CD40-Induced IL-12 Production but Dispensable for Th1 Cell Differentiation1

Kendra Speirs*, Jorge Caamano{dagger}, Michael H. Goldschmidt*, Christopher A. Hunter* and Phillip Scott2,*

* Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104; and {dagger} Medical Research Council Center for Immune Regulation, School of Medicine, University of Birmingham, Edgbaston, Birmingham, United Kingdom

NF-{kappa}B is a ubiquitously expressed transcription factor involved in the regulation of innate and adaptive immunity. As part of studies to define the role of various NF-{kappa}B family members in Th cell development and maintenance, we infected NF-{kappa}B2-/- and control mice with Leishmania major and followed disease progression. NF-{kappa}B2-/- mice on a normally resistant background develop chronic nonhealing lesions associated with uncontrolled parasite replication and a failure to develop an IFN-{gamma} response. We show that there are no intrinsic defects in Th cell differentiation in the absence of NF-{kappa}B2. Indeed, NF-{kappa}B2-/- T cells are able to develop a Th1 phenotype and protect recombination-activating gene-/- mice from progressive cutaneous leishmaniasis. We demonstrate instead that the susceptibility of NF-{kappa}B2-/- mice to L. major is the result of an IL-12 deficiency, and we provide evidence for a specific impairment in CD40-induced IL-12 production by macrophages lacking this transcription factor.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Mise-Omata, E. Kuroda, J. Niikura, U. Yamashita, Y. Obata, and T. S. Doi
A Proximal {kappa}B Site in the IL-23 p19 Promoter Is Responsible for RelA- and c-Rel-Dependent Transcription
J. Immunol., November 15, 2007; 179(10): 6596 - 6603.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Xu, D. Liu, I. Okwor, Y. Wang, H. Korner, S. K. P. Kung, Y.-X. Fu, and J. E. Uzonna
LIGHT Is Critical for IL-12 Production by Dendritic Cells, Optimal CD4+ Th1 Cell Response, and Resistance to Leishmania major
J. Immunol., November 15, 2007; 179(10): 6901 - 6909.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Xu, D. Liu, Y. Fan, X. Yang, H. Korner, Y.-X. Fu, and J. E. Uzonna
Lymphotoxin {alpha}beta2 (Membrane Lymphotoxin) Is Critically Important for Resistance to Leishmania major Infection in Mice
J. Immunol., October 15, 2007; 179(8): 5358 - 5366.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ukil, A. Biswas, T. Das, and P. K. Das
18{beta}-Glycyrrhetinic Acid Triggers Curative Th1 Response and Nitric Oxide Up-Regulation in Experimental Visceral Leishmaniasis Associated with the Activation of NF-{kappa}B
J. Immunol., July 15, 2005; 175(2): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Guizani-Tabbane, K. Ben-Aissa, M. Belghith, A. Sassi, and K. Dellagi
Leishmania major Amastigotes Induce p50/c-Rel NF-{kappa}B Transcription Factor in Human Macrophages: Involvement in Cytokine Synthesis
Infect. Immun., May 1, 2004; 72(5): 2582 - 2589.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Speirs, L. Lieberman, J. Caamano, C. A. Hunter, and P. Scott
Cutting Edge: NF-{kappa}B2 Is a Negative Regulator of Dendritic Cell Function
J. Immunol., January 15, 2004; 172(2): 752 - 756.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. W. Murray, C. M. Lu, E. B. Brooks, R. E. Fichtl, J. L. DeVecchio, and F. P. Heinzel
Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral Leishmaniasis
Infect. Immun., November 1, 2003; 71(11): 6453 - 6462.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Corn, M. A. Aronica, F. Zhang, Y. Tong, S. A. Stanley, S. R. A. Kim, L. Stephenson, B. Enerson, S. McCarthy, A. Mora, et al.
T Cell-Intrinsic Requirement for NF-{kappa}B Induction in Postdifferentiation IFN-{gamma} Production and Clonal Expansion in a Th1 Response
J. Immunol., August 15, 2003; 171(4): 1816 - 1824.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. F. Tomczak, S. E. Erdman, T. Poutahidis, A. B. Rogers, H. Holcombe, B. Plank, J. G. Fox, and B. H. Horwitz
NF-{kappa}B Is Required Within the Innate Immune System to Inhibit Microflora-Induced Colitis and Expression of IL-12 p40
J. Immunol., August 1, 2003; 171(3): 1484 - 1492.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L.-M. Mitsos, L. R. Cardon, L. Ryan, R. LaCourse, R. J. North, and P. Gros
Susceptibility to tuberculosis: A locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs
PNAS, May 27, 2003; 100(11): 6610 - 6615.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. D. Halpern, H. Holubec, J. A. Dominguez, Y. G. Meza, C. S. Williams, M. C. Ruth, R. S. McCuskey, and B. Dvorak
Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis
Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G695 - G702.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Tato, A. Villarino, J. H. Caamano, M. Boothby, and C. A. Hunter
Inhibition of NF-{kappa}B Activity in T and NK Cells Results in Defective Effector Cell Expansion and Production of IFN-{gamma} Required for Resistance to Toxoplasma gondii
J. Immunol., March 15, 2003; 170(6): 3139 - 3146.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Artis, K. Speirs, K. Joyce, M. Goldschmidt, J. Caamano, C. A. Hunter, and P. Scott
NF-{kappa}B1 Is Required for Optimal CD4+ Th1 Cell Development and Resistance to Leishmania major
J. Immunol., February 15, 2003; 170(4): 1995 - 2003.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Artis, S. Shapira, N. Mason, K. M. Speirs, M. Goldschmidt, J. Caamano, H.-C. Liou, C. A. Hunter, and P. Scott
Differential Requirement for NF-{kappa}B Family Members in Control of Helminth Infection and Intestinal Inflammation
J. Immunol., October 15, 2002; 169(8): 4481 - 4487.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. M. Tato and C. A. Hunter
Host-Pathogen Interactions: Subversion and Utilization of the NF-{kappa}B Pathway during Infection
Infect. Immun., July 1, 2002; 70(7): 3311 - 3317.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.